GLRX and metabolic dysfunction-associated steatotic liver disease: Our group reported that Glrx KO mice develop hyperlipidemia, non-alcoholic fatty liver disease [17], and a cardiometabolic phenotype leading to diastolic dysfunction when fed a high fat diet (Osaki, et al. in prep).